Patrick Jozef Maria Smits, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arteriovenous Malformations | 8 | 2023 | 396 | 2.070 |
Why?
|
| MAP Kinase Kinase 1 | 4 | 2023 | 337 | 1.010 |
Why?
|
| Vascular Malformations | 4 | 2023 | 454 | 0.990 |
Why?
|
| Cartilage | 4 | 2018 | 818 | 0.900 |
Why?
|
| Chondrocytes | 7 | 2018 | 804 | 0.840 |
Why?
|
| Achondroplasia | 1 | 2018 | 26 | 0.630 |
Why?
|
| Bone Development | 2 | 2018 | 483 | 0.530 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2020 | 1285 | 0.510 |
Why?
|
| ras Proteins | 1 | 2020 | 1060 | 0.500 |
Why?
|
| High Mobility Group Proteins | 3 | 2006 | 187 | 0.500 |
Why?
|
| Endothelial Cells | 5 | 2023 | 3479 | 0.500 |
Why?
|
| Golgi Apparatus | 2 | 2012 | 410 | 0.470 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 5 | 2021 | 1692 | 0.450 |
Why?
|
| Embryo Loss | 1 | 2012 | 59 | 0.440 |
Why?
|
| Alleles | 4 | 2021 | 6933 | 0.360 |
Why?
|
| Vesicular Transport Proteins | 1 | 2012 | 377 | 0.360 |
Why?
|
| Nuclear Proteins | 4 | 2018 | 5853 | 0.340 |
Why?
|
| Codon, Nonsense | 1 | 2010 | 281 | 0.330 |
Why?
|
| Osteochondrodysplasias | 1 | 2010 | 183 | 0.320 |
Why?
|
| Arteriovenous Fistula | 2 | 2021 | 315 | 0.300 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2020 | 890 | 0.270 |
Why?
|
| Hemangioma | 2 | 2020 | 738 | 0.250 |
Why?
|
| Lymphedema | 2 | 2021 | 534 | 0.250 |
Why?
|
| Phenotype | 5 | 2020 | 16365 | 0.240 |
Why?
|
| Notochord | 1 | 2003 | 36 | 0.230 |
Why?
|
| Embryo, Mammalian | 2 | 2012 | 1701 | 0.220 |
Why?
|
| Growth Plate | 1 | 2004 | 274 | 0.210 |
Why?
|
| Receptor, EphB4 | 1 | 2021 | 38 | 0.200 |
Why?
|
| Receptor, TIE-2 | 1 | 2021 | 178 | 0.200 |
Why?
|
| Mutation | 11 | 2023 | 29786 | 0.190 |
Why?
|
| Sturge-Weber Syndrome | 1 | 2021 | 91 | 0.190 |
Why?
|
| DNA, Complementary | 1 | 2022 | 2050 | 0.170 |
Why?
|
| Osteoblasts | 2 | 2018 | 1166 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 2 | 2018 | 1364 | 0.160 |
Why?
|
| Cartilage Diseases | 1 | 2020 | 160 | 0.160 |
Why?
|
| Signal Transduction | 2 | 2020 | 23403 | 0.160 |
Why?
|
| DNA-Binding Proteins | 3 | 2006 | 9648 | 0.160 |
Why?
|
| Proteoglycans | 2 | 2015 | 835 | 0.160 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 349 | 0.150 |
Why?
|
| Transcription Factors | 4 | 2006 | 12208 | 0.150 |
Why?
|
| Capillaries | 1 | 2020 | 773 | 0.140 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2019 | 356 | 0.140 |
Why?
|
| Cell Differentiation | 4 | 2010 | 11483 | 0.130 |
Why?
|
| SOXD Transcription Factors | 3 | 2006 | 47 | 0.130 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 707 | 0.130 |
Why?
|
| Mice | 11 | 2023 | 81183 | 0.130 |
Why?
|
| Point Mutation | 1 | 2020 | 1623 | 0.130 |
Why?
|
| Enzyme Activation | 1 | 2020 | 3701 | 0.120 |
Why?
|
| Mice, Knockout | 4 | 2018 | 14557 | 0.120 |
Why?
|
| Osteoclasts | 1 | 2018 | 729 | 0.120 |
Why?
|
| Arthritis, Experimental | 1 | 2015 | 291 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 1526 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 1416 | 0.110 |
Why?
|
| Vasodilation | 1 | 1995 | 944 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7722 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 1995 | 977 | 0.100 |
Why?
|
| Animals | 12 | 2023 | 168757 | 0.100 |
Why?
|
| Adenosine | 1 | 1995 | 825 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 17446 | 0.090 |
Why?
|
| Introns | 1 | 2012 | 991 | 0.090 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 2043 | 0.090 |
Why?
|
| Exons | 2 | 2012 | 2437 | 0.080 |
Why?
|
| Osteolysis | 1 | 2010 | 270 | 0.080 |
Why?
|
| Cartilage, Articular | 1 | 2015 | 1095 | 0.080 |
Why?
|
| Homozygote | 1 | 2012 | 1785 | 0.080 |
Why?
|
| Genes, Recessive | 1 | 2010 | 641 | 0.070 |
Why?
|
| Protein Transport | 1 | 2012 | 1988 | 0.070 |
Why?
|
| Knee Joint | 1 | 2015 | 1680 | 0.070 |
Why?
|
| Glycosylation | 1 | 2010 | 1126 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 1995 | 2132 | 0.070 |
Why?
|
| Bone and Bones | 2 | 2010 | 2575 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 1866 | 0.070 |
Why?
|
| Heterozygote | 1 | 2012 | 2804 | 0.070 |
Why?
|
| Receptors, Notch | 1 | 2010 | 739 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2020 | 19229 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2010 | 10481 | 0.060 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2004 | 52 | 0.060 |
Why?
|
| Chondrogenesis | 1 | 2005 | 247 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 1144 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2004 | 105 | 0.060 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2004 | 164 | 0.060 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2004 | 185 | 0.060 |
Why?
|
| Joints | 1 | 2005 | 326 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 1995 | 4456 | 0.060 |
Why?
|
| Gene Targeting | 1 | 2006 | 880 | 0.050 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2004 | 331 | 0.050 |
Why?
|
| Mesoderm | 1 | 2005 | 686 | 0.050 |
Why?
|
| Synovial Membrane | 1 | 2005 | 507 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2004 | 569 | 0.050 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2021 | 39 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2012 | 4161 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 1990 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 2703 | 0.050 |
Why?
|
| Hedgehog Proteins | 1 | 2004 | 783 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2004 | 838 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 4803 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2004 | 2726 | 0.040 |
Why?
|
| Humans | 16 | 2021 | 744343 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 2529 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 3002 | 0.040 |
Why?
|
| Time Factors | 2 | 2012 | 40075 | 0.040 |
Why?
|
| Pregnancy | 2 | 2012 | 29144 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2005 | 2504 | 0.040 |
Why?
|
| Cell Division | 1 | 2004 | 4568 | 0.030 |
Why?
|
| Tolbutamide | 1 | 1995 | 23 | 0.030 |
Why?
|
| omega-N-Methylarginine | 1 | 1995 | 111 | 0.030 |
Why?
|
| Quinidine | 1 | 1995 | 57 | 0.030 |
Why?
|
| Nitroprusside | 1 | 1995 | 275 | 0.030 |
Why?
|
| Plethysmography | 1 | 1995 | 180 | 0.030 |
Why?
|
| Adolescent | 5 | 2021 | 85781 | 0.030 |
Why?
|
| Gestational Age | 1 | 2004 | 3493 | 0.030 |
Why?
|
| Verapamil | 1 | 1995 | 244 | 0.030 |
Why?
|
| Female | 10 | 2021 | 380194 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 2455 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 2866 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2004 | 2924 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2915 | 0.030 |
Why?
|
| Forearm | 1 | 1995 | 409 | 0.030 |
Why?
|
| Male | 8 | 2021 | 350118 | 0.030 |
Why?
|
| Cell Survival | 1 | 2003 | 5882 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1995 | 563 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1995 | 916 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2021 | 6171 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 1995 | 1525 | 0.030 |
Why?
|
| Arginine | 1 | 1995 | 944 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 3703 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 15519 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2006 | 21827 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 56430 | 0.020 |
Why?
|
| Prognosis | 2 | 2020 | 29063 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 1578 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 9583 | 0.020 |
Why?
|
| Proteins | 1 | 2004 | 6103 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2004 | 7880 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2010 | 1341 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2010 | 644 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 2085 | 0.020 |
Why?
|
| Adult | 4 | 2021 | 214055 | 0.020 |
Why?
|
| Chimera | 1 | 2006 | 485 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 3798 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2010 | 3689 | 0.010 |
Why?
|
| Integrases | 1 | 2006 | 533 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 10943 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3870 | 0.010 |
Why?
|
| Hindlimb | 1 | 2005 | 504 | 0.010 |
Why?
|
| Synovial Fluid | 1 | 2005 | 394 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 20822 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.010 |
Why?
|
| Surface Properties | 1 | 2005 | 1184 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 1246 | 0.010 |
Why?
|
| Child | 2 | 2020 | 77709 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1950 | 0.010 |
Why?
|
| Joint Diseases | 1 | 2005 | 480 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13284 | 0.010 |
Why?
|
| Syndrome | 1 | 2005 | 3251 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2006 | 2751 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 3144 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 41006 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 40561 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 18029 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 6622 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 5867 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 9727 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 16689 | 0.010 |
Why?
|
| Radiography | 1 | 2005 | 7023 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 213383 | 0.000 |
Why?
|